Developmental Trajectories of Anhedonia in Preclinical Models.
Developmental Trajectories of Anhedonia in Preclinical Models.
复制标题
DOI:
10.1007/7854_2021_299
复制
发表时间:
2022
影响因子:
--
通讯作者:
Baram, Tallie Z
中科院分区:
文献类型:
--
作者:
Birnie, Matthew T;Levis, Sophia C;Mahler, Stephen V;Baram, Tallie Z
This chapter discusses how the complex concept of anhedonia can be operationalized and studied in preclinical models. It provides information about the development of anhedonia in the context of early life adversity, and the power of preclinical models to tease out the diverse molecular, epigenetic and network mechanisms that are responsible for anhedonia-like behaviors. Specifically, we first discuss the term anhedonia, reviewing the conceptual components underlying reward-related behaviors and distinguish anhedonia pertaining to deficits in motivational versus consummatory behaviors. We then describe the repertoire of experimental approaches employed to study anhedonia-like behaviors in preclinical models, and the progressive refinement over the past decade of both experimental instruments (e.g., chemogenetics, optogenetics) and conceptual constructs (salience, valence, conflict). We follow with an overview of the state of current knowledge of brain circuits, nodes and projections that execute distinct aspects of hedonic-like behaviors, as well as neurotransmitters, modulators and receptors involved in the generation of anhedonia-like behaviors. Finally, we discuss the special case of anhedonia that arises following early-life adversity as an eloquent example enabling the study of causality, mechanisms and sex dependence of anhedonia. Together, this chapter highlights the power, potential and limitations of using pre-clinical models to advance our understanding of the origin and mechanisms of anhedonia and to discover potential targets for its prevention and mitigation.